![Photo](/media/story/21624/thumbnail-01-shutterstock-1180741114-kateryna-kon.jpg)
Article • Boosting our immune surveillance
Antibodies PD-1 and PD-L1: a quantum leap in cancer therapy
Immuno-oncology is a therapy in which the body’s immune system treats a tumour. Dr Eric Borges, from the Research and Development Centre at Boehringer Ingelheim Pharma GmbH in Germany, explains why this is revolutionary. Unlike conventional cancer therapies, with immuno-oncology the tumour cell is not the direct target, it’s the patient’s immune system. The medication stimulates this to…